St. Jude Medical, Inc.
St. Jude Medical, Inc. Fundamental Analysis
St. Jude Medical, Inc. (STJ) shows moderate financial fundamentals with a PE ratio of 25.92, profit margin of 15.88%, and ROE of 21.36%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 59.0/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze STJ's fundamental strength across five key dimensions:
Efficiency Score
WeakSTJ struggles to generate sufficient returns from assets.
Valuation Score
ModerateSTJ shows balanced valuation metrics.
Growth Score
WeakSTJ faces weak or negative growth trends.
Financial Health Score
ModerateSTJ shows balanced financial health with some risks.
Profitability Score
ModerateSTJ maintains healthy but balanced margins.
Key Financial Metrics
Is STJ Expensive or Cheap?
P/E Ratio
STJ trades at 25.92 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, STJ's PEG of 0.26 indicates potential undervaluation.
Price to Book
The market values St. Jude Medical, Inc. at 5.64 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -4.07 times EBITDA. This is generally considered low.
How Well Does STJ Make Money?
Net Profit Margin
For every $100 in sales, St. Jude Medical, Inc. keeps $15.88 as profit after all expenses.
Operating Margin
Core operations generate 18.59 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $21.36 in profit for every $100 of shareholder equity.
ROA
St. Jude Medical, Inc. generates $6.74 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $3.02 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
25.92
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.26
vs 25 benchmark
P/B Ratio
Price to book value ratio
5.64
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.58
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.32
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.21
vs 25 benchmark
ROA
Return on assets percentage
0.07
vs 25 benchmark
ROCE
Return on capital employed
0.10
vs 25 benchmark
How STJ Stacks Against Its Sector Peers
| Metric | STJ Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 25.92 | 28.45 | Neutral |
| ROE | 21.36% | 763.00% | Weak |
| Net Margin | 15.88% | -45265.00% (disorted) | Strong |
| Debt/Equity | 1.58 | 0.34 | Weak (High Leverage) |
| Current Ratio | 1.32 | 2795.60 | Neutral |
| ROA | 6.74% | -16588.00% (disorted) | Weak |
STJ outperforms its industry in 1 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews St. Jude Medical, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation